Form 4: Bioventus Inc. Executive Katrina J. Church Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4
Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., reports the acquisition of stock options and restricted stock units.
Summary
- On March 15, 2024, Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., acquired 17,500 restricted stock units (RSUs) that vest in four equal installments on the first four anniversaries of February 15, 2024.
- She also acquired 26,875 RSUs that vest on June 15, 2024.
- Additionally, Church acquired options to purchase 40,000 shares of Class A Common Stock at an exercise price of $5.45, which vest in four equal installments on the first four anniversaries of February 15, 2024, and expire on March 15, 2034.
- Following these transactions, Church directly owns 17,500 RSUs and 26,875 RSUs, and options to purchase 40,000 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning management interests with shareholders through equity ownership.
Positives
- The acquisition of stock options and RSUs aligns the executive's interests with those of the shareholders.
- The vesting schedules incentivize continued service with the company.
Industry Context
This filing is a routine disclosure of executive compensation in the form of stock options and restricted stock units, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Comparison to Industry Standards
- Stock option and RSU grants are a standard component of executive compensation packages in publicly traded companies, including those in the medical device and biotechnology sectors.
- Companies like Stryker, Zimmer Biomet, and Medtronic also utilize similar equity-based compensation plans to align executive interests with shareholder value.
Stakeholder Impact
- The granting of stock options and RSUs can positively impact shareholders by aligning executive interests with the long-term performance of the company.
- Employees may view this as a positive sign of investment in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 02/15/2024 | Date from which the RSUs and options vest in four equal installments on each of the first four anniversaries. |
| 03/15/2024 | Date of the transaction where the reporting person acquired RSUs and stock options. |
| 03/15/2024 | Stock options expire 10 years from this date. |
| 06/15/2024 | Date on which 26,875 RSUs shall vest. |
| 03/22/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.